Top news of the week: 15.09.2021.
Startups
Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest
The funding is likely to force policymakers to engage more directly with what has until now seemed more science fiction than reality.
Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech To Unicorn Status
Investors are betting the protein toolbox of the four-year-old startup can solve one of gene therapy’s trickiest problems: getting treatments into the patient’s body.
Early data suggest monthly hemophilia drug could contend with gene therapy
The company’s drug significantly reduced the rate of bleeding for patients with hemophilia A and B in a small study.
A closer look at venture capital in the Netherlands
In this blog post, we explore the venture capital landscape in the Netherlands, including the top Dutch VC firms by AUM and top VC deals done by Dutch VC firms by deal size.
Fred Frank, co-founder of the biotech industry, is dead at 89
Frederick Frank, one of the founding fathers of biotech investment banking who transformed the sector by constructing the first Genentech-Roche deal, passed away Saturday.
Remembering Fred Frank, a giant of biotech
Fred is gone. A true giant of the biotechnology industry has left this world, but his imprint has not left the industry.
Healthy Ventures partners with founders seeking hybrid ears to hear. Firm understanding of the idiosyncratic healthcare vertical + Horizontal playbook of what's worked before, better in other markets We think of it as 'Learning Curve Arbitrage'.
Besides investing, Enmi has worked with operating companies of varying sizes anchored around consumer marketing. Enmi graduated from Harvard University with an AB cum laude in …
A top cannabis VC says he's pivoting to psychedelics to find the next billion-dollar startups
"I want to go in early when it's most scary, most risky, and where I see the biggest opportunity," said Phyto Partners' Larry Schnurmacher.